Sex, drugs, and rock and roll chemistry in the brain

The same brain-chemical system that mediates feelings of pleasure from sex, recreational drugs, and food is also critical to experiencing musical pleasure, according to a study by McGill University researchers published today in the Nature journal Scientific Reports.

"This is the first demonstration that the brain's own opioids are directly involved in musical pleasure," says cognitive psychologist Daniel Levitin, senior author of the paper. While previous work by Levitin's lab and others had used neuroimaging to map areas of the brain that are active during moments of musical pleasure, scientists were able only to infer the involvement of the opioid system.

In the new study, Levitin's team at McGill selectively and temporarily blocked opioids in the brain using naltrexone, a widely prescribed drug for treating addiction disorders. The researchers then measured participants' responses to music, and found that even the participants' favorite songs no longer elicited feelings of pleasure.

"The findings, themselves, were what we hypothesized," Levitin says. "But the anecdotes - the impressions our participants shared with us after the experiment - were fascinating. One said: 'I know this is my favorite song but it doesn't feel like it usually does.' Another: 'It sounds pretty, but it's not doing anything for me.'"

Things that people enjoy - alcohol, sex, a friendly game of poker, to name a few - can also lead to addictive behaviors that can harm lives and relationships. So understanding the neurochemical roots of pleasure has been an important part of neuroscience research for decades. But scientists only recently developed the tools and methods to do such research in humans.

Still, this study proved to be "the most involved, difficult and Sisyphean task our lab has undertaken in 20 years of research," Levitin says. "Anytime you give prescription drugs to college students who don't need them for health reasons, you have to be very careful to ensure against any possible ill effects." For example, all 17 participants were required to have had a blood test within the year preceding the experiment, to ensure they didn't have any conditions that would be made worse by the drug.

Music's universality and its ability to deeply affect emotions suggest an evolutionary origin, and the new findings "add to the growing body of evidence for the evolutionary biological substrates of music," the researchers write.

This work was supported by funding from the Natural Sciences and Engineering Research Council of Canada.

Mallik A, Chanda ML, Levitin DJ.
Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone.
Sci. Rep. 7, 41952; doi: 10.1038/srep41952.

Most Popular Now

A need for bananas? Dietary potassium regulates ca…

Bananas and avocados - foods that are rich in potassium - may help protect against pathogenic vascular calcification, also known as hardening of the arteries. University ...

FDA awards 15 grants for clinical trials to stimul…

The U.S. Food and Drug Administration today announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to...

Amgen and CytomX Therapeutics announce strategic c…

Amgen (NASDAQ:AMGN) and CytomX Therapeutics, Inc., (NASDAQ:CTMX) today announced that the companies have entered into a strategic collaboration in immuno-oncology. The co...

Novartis and The Max Foundation transform pioneeri…

Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current patients with chronic myeloid...

Roche launches NAVIFY Tumor Board solution to prov…

Roche (SIX: RO, ROG; OTCQX:RHHBY), has announced the launch of the NAVIFY Tumor Board solution, a clinical workflow and decision support software that optimises decision-...

AbbVie and Bristol-Myers Squibb announce clinical …

AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a clinical trial collaboration to evaluate the combination of AbbVie's investigational an...

Tagrisso granted breakthrough therapy designation …

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Tagrisso (osimertinib) for the 1st-line treatm...

Pfizer launches novel programs to put important su…

Pfizer today unveils enhanced offerings to help patients manage their life with cancer. Pfizer Oncology Together is a first-of-its-kind program for patients taking Pfizer...

Novartis and UC Berkeley collaborate to tackle 'un…

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pu...

Printed meds could reinvent pharmacies, drug resea…

A technology that can print pure, ultra-precise doses of drugs onto a wide variety of surfaces could one day enable on-site printing of custom-dosed medications at pharma...

Danish discovery can pave the way for more effecti…

More than 600,000 Danes are being treated with cholesterol lowering medicine. 98 per cent of them are treated with statins, which curb the body's own production of choles...

Amgen and Simcere announce strategic collaboration…

Amgen (NASDAQ: AMGN) and Simcere Pharmaceutical Group have announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China. Th...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]